Moody SE, Schinzel AC, Singh S, et al. PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling. Oncogene. 2015;34(16):2061-71. doi:10.1038/onc.2014.153
Pugh TJ, Yu W, Yang J, et al. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene. 2014;33(45):5295-302. doi:10.1038/onc.2014.150
Wang J, Mikse O, Liao RG, et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene. 2015;34(17):2167-77. doi:10.1038/onc.2014.161
Escott-Price V, Bellenguez C, San Wang L, et al. Gene-wide analysis detects two new susceptibility genes for Alzheimer’s disease. PLoS One. 2014;9(6):e94661. doi:10.1371/journal.pone.0094661
Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396-401. doi:10.1126/science.1254257
Yamamoto S, Wu Z, Russnes HG, et al. JARID1B is a luminal lineage-driving oncogene in breast cancer. Cancer Cell. 2014;25(6):762-77. doi:10.1016/j.ccr.2014.04.024
Jaiswal S, Ebert BL. MDS is a stem cell disorder after all. Cancer Cell. 2014;25(6):713-4. doi:10.1016/j.ccr.2014.06.001
Dugan VG, Emrich SJ, Giraldo-Calderón GI, et al. Standardized metadata for human pathogen/vector genomic sequences. PLoS One. 2014;9(6):e99979. doi:10.1371/journal.pone.0099979
Olsson M, Frankowiack M, Tengvall K, et al. The dog as a genetic model for immunoglobulin A (IgA) deficiency: identification of several breeds with low serum IgA concentrations. Vet Immunol Immunopathol. 2014;160(3-4):255-9. doi:10.1016/j.vetimm.2014.05.010
Grgic I, Hofmeister AF, Genovese G, et al. Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo. Kidney Int. 2014;86(6):1116-29. doi:10.1038/ki.2014.204